Capricor Therapeutics | CAPR - Beneficio Bruto En Ventas

Precio De Mercado
29.24
Cambio Diario
0.14 0.48%
Mensual
4.77%
Anual
120.18%
Q1 Expectativa
28.23




Beneficio Bruto En Ventas Cambio Fecha
Bioline Rx USD 343K 111K 2025-09
Capricor Therapeutics 11.13M 8.87M 2024-12
Cipla INR 41.64B 6.31B 2025-12
Cytokinetics USD 17.76M 15.82M 2025-12
Geron USD 46.71M 525K 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Immunic 0 0 2025-03
J&J USD 16.6B 118M 2025-12
Prothena USD 21K 2.39M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12